Citigroup’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $367K | Buy |
27,118
+6,125
| +29% | +$82.9K | ﹤0.01% | 3082 |
|
|
2025
Q1 | $333K | Sell |
20,993
-2,371
| -10% | -$37.7K | ﹤0.01% | 3146 |
|
|
2024
Q4 | $288K | Buy |
23,364
+1,391
| +6% | +$17.1K | ﹤0.01% | 3356 |
|
|
2024
Q3 | $266K | Buy |
21,973
+14,214
| +183% | +$172K | ﹤0.01% | 3393 |
|
|
2024
Q2 | $90.8K | Buy |
7,759
+3,803
| +96% | +$44.5K | ﹤0.01% | 3534 |
|
|
2024
Q1 | $51.1K | Buy |
3,956
+145
| +4% | +$1.87K | ﹤0.01% | 3875 |
|
|
2023
Q4 | $32.8K | Buy |
3,811
+3,805
| +63,417% | +$32.7K | ﹤0.01% | 3990 |
|
|
2023
Q3 | $57 | Sell |
6
-4,148
| -100% | -$39.4K | ﹤0.01% | 4740 |
|
|
2023
Q2 | $70.8K | Buy |
+4,154
| New | +$70.8K | ﹤0.01% | 3753 |
|